Document is current
Any future updates will be listed below
-
Authors
Noor, Nurulamin M.
Raine, Tim https://orcid.org/0000-0002-5855-9873
- License Information
-
More Information
Article History
First Online: 12 June 2023
Competing interests
: N.M.N. has received educational grants and/or speaker fees from AbbVie, Dr Falk Pharma, Galapagos, Gilead, Janssen, Pfizer, Pharmacosmos, PredictImmune, SBK Healthcare, Takeda and Tillotts Pharma AG; all outside of the submitted work. T.R. has received research/educational grants and/or speaker/consultation fees from Abbvie, Arena, Aslan, AstraZeneca, BMS, Boehringer-Ingelheim, Celgene, Ferring, Galapagos, Gilead, GSK, Hepatares, LabGenius, Janssen, Mylan, MSD, Novartis, Pfizer, Sandoz, Takeda, UCB and XAP therapeutics; all outside of the submitted work.
